Your First 30 Days on GLP-1 in India: A Week-by-Week Guide to What to Expect

Your First 30 Days on GLP-1 in India: A Week-by-Week Guide to What to Expect

Starting a GLP-1 medication like Ozempic (semaglutide), Victoza (liraglutide), or Rybelsus (oral semaglutide) raises many questions — and the first 30 days are when most of them get answered. This period brings the first real encounter with side effects, the first glimmer of results, and the most critical decisions about whether to continue, slow down, or adjust your approach.

This guide walks through what Indian patients typically experience week by week in the first month — what is normal, what is worth monitoring, and what requires a call to your doctor.

Consult your healthcare provider before starting any medication or making any changes to your treatment plan.

Before Day 1: What to Have Ready

Before your first injection or tablet, set yourself up for success:

• Baseline blood tests: Fasting blood glucose, HbA1c, serum ferritin, kidney function (creatinine/eGFR), liver function, TSH, and a full blood count. These give you a reference point to measure progress against — and may reveal deficiencies that need addressing from day one.
• A pen to record your experience: Note daily nausea level (1–10), any vomiting, bowel changes, energy levels, and blood sugar readings if relevant. This log becomes invaluable at your first follow-up appointment.
• Small, protein-rich food stocks at home: On nauseous days, you will not want to cook. Keep hung curd, boiled eggs, roasted chana, and paneer cubes in the fridge.
• Insulin or oral diabetes medication awareness: If you are on sulphonylureas (glimepiride, glibenclamide) or insulin alongside your GLP-1, confirm with your doctor whether doses should be pre-emptively reduced to avoid hypoglycaemia.

Week 1: The Body Learns — Days 1 to 7

For Ozempic users: You inject your first 0.25 mg dose and wait.

For Rybelsus users: You take your first 3 mg tablet on an empty stomach, 30 minutes before food.

What most people experience:

• Mild nausea, usually in the hours after the injection or after eating
• Some people feel virtually nothing; others feel quite queasy
• Constipation or, less commonly, loose stools beginning around day 3–4
• A slight reduction in appetite — noticeable as feeling full sooner than usual
• No significant weight change yet (1–3 days of reduced eating may account for 0.5–1 kg of scale movement, mostly water)

What most people do NOT experience yet:

• Significant blood sugar improvement (one week is too early for most)
• Major hunger reduction — this typically builds over weeks
• Any weight change beyond day-to-day fluctuation

India-specific note: Many Indian patients take their first Ozempic injection at the clinic. Ask your doctor or pharmacist to demonstrate the pen mechanism — the click confirmation and needle attachment process. Watching a video (Novo Nordisk India has official guides) before your first self-injection at home helps considerably.

Week 2: Side Effects Settle — Days 8 to 14

What most people experience:

• Nausea patterns begin to clarify — you start to identify whether it is worse after certain foods (fatty, oily, or very spicy food is a common trigger), after lying down, or at a consistent time of day
• Appetite reduction often becomes more noticeable — finishing a usual-sized meal may feel impossible
• You may notice yourself thinking about food less
• Burping or belching after meals is common and normal
• Energy may be slightly lower than usual — some people attribute this to eating less

Blood sugar response: For patients with type 2 diabetes, fasting blood sugar may begin to drop slightly by week 2. If you are monitoring at home, you may notice fasting readings 10–20 mg/dL lower than before starting.

Common mistake at this stage: Many patients see the appetite suppression kick in and dramatically reduce their food intake, sometimes eating fewer than 600–800 kcal per day. This causes muscle loss, nutritional deficiencies, fatigue, and — paradoxically — makes some side effects worse. Aim for a minimum of 1,000–1,200 kcal per day even if your appetite allows much less.

Week 3: The Adaptation Window — Days 15 to 21

What most people experience:

• Side effects begin to ease for most people — nausea frequency and intensity tends to reduce toward the end of the third week
• Some people experience a second wave of constipation if they have not been hydrating and eating fibre adequately
• Appetite suppression is now quite consistent — most people are eating noticeably smaller portions
• For weekly injection users (Ozempic): the third injection may feel more manageable than the first two

What to watch:

• Constipation is very common in India during week 3 — increase fluid intake (2.5–3 litres of water per day), include fibre sources (raw salad, psyllium husk / isabgol, high-fibre dal), and consider a short walk after meals to stimulate bowel movement
• If nausea is still severe at week 3 (grade 3–4 out of 5, affecting your ability to work or function), this warrants a conversation with your doctor about whether to delay the week 4 dose increase or remain at 0.25 mg for a second month

Scale changes: Most people see 1–2 kg of actual weight loss by week 3, primarily from reduced calorie intake. This is real fat and water loss, not dramatic — but it is a meaningful early signal.

Week 4: First Stocktaking — Days 22 to 30

What most people experience:

• Stable appetite suppression — the medication is now working consistently
• Most side effects from the initial weeks have reduced significantly
• A clearer sense of what food triggers discomfort and what works well
• Energy starting to recover as the body adapts to lower calorie intake
• Many people notice that their relationship with food has changed — the constant background noise of hunger and food craving has quietened

Typical outcomes by end of month 1:

Important note: These are population averages. Some people lose more, some less. Comparing your week 4 results to someone who has been on a therapeutic dose for 6 months is not valid — you are still on the starter dose and still adapting.

Common First-Month Mistakes Indian Patients Make

1. Eating too little As noted above, the combination of GLP-1-induced appetite suppression and cultural pressure to "make the most of the medication" leads many patients to eat dangerously little. Prioritise protein and do not let total daily calories drop below 1,000–1,200 kcal without medical supervision.

2. Eating oily and spicy food unchanged A dal makhani made with heavy cream, double-butter butter chicken, or deep-fried starters are not compatible with a GLP-1-slowed gut. Many people in their first month make themselves severely nauseous by not adjusting their diet. Shift toward lighter preparations of favourite dishes — dry tandoor rather than gravy, grilled rather than fried.

3. Expecting visible results in 30 days The first month is about adaptation and tolerability — not about dramatic transformation. Clinical trials show that the most meaningful weight loss typically begins after the dose is escalated (months 2–3). If you expect dramatic results by day 30, you will be disappointed.

4. Skipping the injection because of nausea Many people skip an injection during a particularly nauseous week. This resets adaptation, meaning the next injection may trigger side effects as though it were the first. Unless you are medically unwell, maintaining the injection schedule — even through moderate nausea — produces better long-term tolerance.

5. Not telling family members Indian family meals involve pressure to eat more, second helpings, and concern if you eat small portions. Being open with immediate family about your medication and its effects prevents awkward situations and allows them to support rather than undermine your progress.

Managing Side Effects: First-Month Toolkit

When to Call Your Doctor During Month 1

Always contact your prescribing doctor promptly if you experience:

• Vomiting that prevents you from keeping any fluids down for more than 24 hours
• Severe abdominal pain, especially pain radiating to the back
• Signs of dehydration: no urination for more than 8 hours, rapid heartbeat, extreme dizziness
• Symptoms of hypoglycaemia if you are also on insulin or sulphonylureas
• Significant mood changes or anxiety that feels linked to starting the medication

Frequently Asked Questions — First Month

Q: I have been on Ozempic for 3 weeks and have not lost any weight. Is it working? At 3 weeks on the 0.25 mg starter dose, weight loss of 0–1 kg is completely typical. The starter dose is not a therapeutic dose — it is preparing your body for treatment. Expect results to build after month 2.

Q: My nausea is mild but constant. Should I eat through it? Yes, in most cases. Eating small, plain, protein-rich foods (plain curd, a boiled egg, thin dal) is better than not eating. Eating in a reclined position worsens nausea — sit upright for 30–45 minutes after eating.

Q: My family thinks I am taking too little food. What do I tell them? Tell them your medication reduces appetite as a deliberate mechanism, not a side effect of feeling unwell. Show them this or similar informational articles. A conversation with your doctor during a family visit can also help family members understand the treatment.

Q: Can I drink alcohol in the first month? Alcohol is not prohibited, but it worsens nausea significantly in the first month of GLP-1 therapy and disrupts blood sugar control. Most doctors advise minimising alcohol — especially spirits and beer — for at least the first 4–6 weeks.

Summary

The first 30 days on GLP-1 therapy in India are about adaptation, not transformation. Week 1 brings the first encounter with nausea and appetite changes; week 2 reveals patterns; week 3 typically sees side effects easing; week 4 brings the first clear picture of how the medication will affect your daily life. Protect your nutrition during this period, adjust your diet for GLP-1 compatibility, and maintain realistic expectations. The foundation you lay in month 1 determines how successfully you navigate the months of meaningful results that follow.

This article is for informational purposes only. Consult your healthcare provider before starting any medication or making any changes to your treatment plan.